Related Experiment Video
Updated: Jun 29, 2026
Employing the Forced Oscillation Technique for the Assessment of Respiratory Mechanics in Adults
Published on: February 9, 2022
Reproducibility of spirometry during cystic fibrosis pulmonary exacerbations
Don B Sanders1, Margaret Rosenfeld1, Nicole Mayer-Hamblett1
1Pediatric Pulmonary Division, Department of Pediatrics, Children's Hospital & Regional Medical Center, University of Washington, Seattle, Washington.
Insights
Pulmonary exacerbations in children with cystic fibrosis (CF) do not significantly increase day-to-day spirometry variation. Spirometry variability in CF patients during exacerbations is comparable to that of stable patients.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Cystic Fibrosis Research
Background:
- Spirometry is crucial for monitoring cystic fibrosis (CF) lung function.
- Pulmonary exacerbations can impact respiratory status and potentially spirometry reliability.
- Understanding spirometry variability during exacerbations is key for accurate clinical assessment.
Purpose of the Study:
- To compare within-day spirometry variation in children with CF during hospital admission, discharge, and outpatient follow-up.
- To determine if acute pulmonary exacerbations increase spirometry variability.
- To establish measurement variability thresholds for detecting meaningful changes in CF lung function.
Main Methods:
- Retrospective review of spirometry data from pediatric CF patients (>=6 years) admitted for pulmonary exacerbations.
- Analysis of spirometry data within 3 days of admission, discharge, and at follow-up visits.
- Comparison of within-day coefficients of variation (CV) for FVC, FEV1, and FEF25-75 using Wilcoxon signed-rank test.
Main Results:
- No significant difference in spirometry CV was found between admission, discharge, and follow-up time points.
- Mean CVs were comparable to previous reports for stable CF outpatients.
- Identified spirometry changes exceeding measurement variability: 80 ml for FVC, 70 ml for FEV1, and 220 ml/sec for FEF25-75.
Conclusions:
- Acute pulmonary exacerbations do not substantially increase within-day spirometry variation in children with CF.
- Spirometry variability during exacerbations is similar to that observed in clinically stable CF patients.
- This suggests spirometry remains a reliable measure even during acute illness.
Objectives:
To compare the within day variation of spirometry between hospital admission, discharge, and outpatient follow up among children with cystic fibrosis (CF) hospitalized for a pulmonary exacerbation.
Hypothesis:
Within day variation of spirometry will be greater at hospital admission than at hospital discharge or outpatient follow up.
Methods:
We performed a retrospective review of spirometry data for all patients with CF >or=6 years old admitted to our pediatric CF center for a pulmonary exacerbation in 2004 or 2005. For patients who had previously performed spirometry successfully, measurements were used from one admission only during 2004-2005 if the spirometry occurred within 3 days of hospital admission, 3 days of discharge, or at a follow up clinic visit when well. We compared the within day coefficients of variation (CV) for FVC, FEV(1), and FEF(25-75) between time points using the Wilcoxon signed rank-test. We also determined the change in spirometry that is likely to be beyond measurement variability during inpatient treatment of a pulmonary exacerbation.
Results:
Spirometry data were available from 40 subjects at admission and follow up and 35 at hospital discharge. There was no significant difference in CV at admission, discharge, and follow up for FVC, FEV(1), or FEF(25-75). The mean (SD) CV was 3.1% (2.7) for FVC, 3.2% (2.1) for FEV(1), and 9.7% (7.0) for FEF(25-75) at admission, 2.8% (2.2) for FVC, 3.1% (2.1) for FEV(1), and 8.1% (6.7) for FEF(25-75) at discharge, and 2.7% (1.7) for FVC, 2.8% (2.0) for FEV(1), and 8.4% (7.8) for FEF(25-75) at follow up. These are similar to previous reports of outpatients with CF. The improvement in spirometry that exceeded measurement variability for our cohort was 80 ml for FVC, 70 ml for FEV(1), and 220 ml/sec for FEF(25-75).
Conclusions:
The presence of an acute pulmonary exacerbation in children and adolescents with CF does not substantially contribute to the within day variation in spirometry. Within day variation of spirometry for children with CF during pulmonary exacerbations is similar to previously reported values from clinically stable CF patients.
Related Concept Videos
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
01:25Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:23Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...